Prelude Therapeutics Inc (PRLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 218,309 | 18,879 | N/A | N/A | N/A |
| TOTAL | $220,809 | $20,224 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 2,480 | 1,647 | N/A | N/A | N/A |
| Other Non-Current Assets | 301 | 0 | 0 | 0 | 0 |
| TOTAL | $2,781 | $1,647 | $N/A | $N/A | $N/A |
| Total Assets | $223,590 | $21,871 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,920 | 1,974 | 0 | 0 | 0 |
| Accrued Expenses | 7,455 | 2,603 | N/A | N/A | N/A |
| TOTAL | $11,375 | $4,835 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 32 | 5 | 0 | 0 | 0 |
| TOTAL | $32 | $5 | $N/A | $N/A | $N/A |
| Total Liabilities | $11,407 | $4,840 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,586 | N/A | N/A | N/A | N/A |
| Common Shares | 4 | N/A | N/A | N/A | N/A |
| Retained earnings | -107,426 | -50,497 | N/A | N/A | N/A |
| Other shareholders' equity | 0 | 66,443 | 0 | 0 | 0 |
| TOTAL | $212,183 | $17,031 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $223,590 | $21,871 | $0 | $0 | $0 |